Morepen Laboratories Share Price (MOREPENLAB)
Check the latest share price of Morepen Laboratories, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
₹63.81
as on 04:01PM, 04 Jun 2025
NSE
Morepen Laboratories Stock Performance
Get live Morepen Laboratories share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹62.66Day's Price Range₹64.9252 Week's Low
52 Week's High
₹4252-Week Price Range₹100.9
| Returns % | |
| 1 Month Return | + 5.78 % |
| 3 Month Return | + 40.12 % |
| 1 Year Return | + 48.97 % |
| 3 Year Return | + 56.56 % |
| 5 Year Return | + 261.79 % |
| Market Stats | |
| Previous Close | ₹64.58 |
| Open | ₹64.70 |
| Volume | 34.57L |
| Upper Circuit | ₹77.49 |
| Lower Circuit | ₹51.66 |
Morepen Laboratories Fundamentals & Key Indicators
Check Morepen Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹3,538.68 Cr
Return on Equity (ROE)
13.29
PE Ratio (TTM)
29.35
Return on capital employed (ROCE)
17.08
Industry PE ratio
55.92
Beta (LTM)
1.65
P/B Ratio
2.42
Dividend Yield
0PEG Ratio
91.73
Quarterly Earnings Growth YOY
-29.33
EPS (TTM)
1.89
Sector
Pharmaceuticals
Book Value
16.58
Technical Analysis
Bullish
View Technical Analysis
How to invest in Morepen Laboratories?
Investing in Morepen Laboratories is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Morepen Laboratories or MOREPENLAB on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Morepen Laboratories or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Morepen Laboratories with just a few clicks!
Morepen Laboratories Stock's Interest Amongst Investors
Morepen Laboratories Valuation
Track how Morepen Laboratories P/E has moved over time to understand its valuation trends.
Morepen Laboratories in the last 5 years
Lowest (10.48x)
March 23, 2020
Today (29.35x)
June 3, 2025
Industry (55.92x)
June 3, 2025
Highest (64.70x)
January 22, 2018
Today’s Price to Earnings Ratio: 29.35x
Morepen Laboratories Financial Results
Get the annual and quarterly financial summary of Morepen Laboratories, including revenue, profit, loss and more.
Indices Featuring Morepen Laboratories Stock
Check stock indices that include Morepen Laboratories.
Morepen Laboratories Earnings and Dividends
View detailed summary of the earnings and dividend history of Morepen Laboratories.
Morepen Laboratories Ltd Earnings Results
Morepen Laboratories Ltd’s net profit fell -28.15% since last year same period to ₹20.32Cr in the Q4 2024-2025. On a quarterly growth basis, Morepen Laboratories Ltd has generated -23.87% fall in its net profits since last 3-months.
Read More about Earnings Results
Morepen Laboratories Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Morepen Laboratories.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 35.65% | 0.00 | |
| Foreign Institutions | 1.94% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 60.72% | 0.00 | |
| Others | 1.68% | 0.00 |
Morepen Laboratories vs Peers
Compare market cap, revenue, PE, and other key metrics of Morepen Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 3,538.68 | 52.36% | 0.53 | NA | NA | |
| NA | 0.00 | -11.37% | 0.77 | NA | NA | |
| NA | 23,341.25 | 40.67% | 0.00 | NA | NA | |
| NA | 34.33 | 13.59% | 0.54 | NA | NA | |
| BUY | 5,752.91 | 16.58% | 0.50 | NA | NA |
Morepen Laboratories News & Key Events
Latest news and events in one place to help you make informed investing decisions in Morepen Laboratories.
Morepen Laboratories Secures Rs 50 Crore Loan - 23 May, 2025
Morepen Laboratories' Board approved a Rs 50 crore loan facility from Qatar National Bank, enhancing liquidity for operational needs without equity implications.Morepen Labs Reports Q4 Profit Decline - 12 May, 2025
Morepen Laboratories reported a 31% drop in consolidated net profit to Rs 20 crore for Q4 FY25, while total income increased to Rs 470 crore. The board approved a final dividend of Rs 0.20 per share and plans to establish a wholly-owned subsidiary in Dubai to expand market access.Morepen Labs Advances NASH Treatment Development - 29 Apr, 2025
Morepen Laboratories has received CDSCO approval to conduct bioequivalence studies for Resmetirom tablets, targeting non-alcoholic steatohepatitis (NASH). This positions Morepen as a key player in the growing NASH treatment market, projected to expand significantly by 2032.Morepen Laboratories Stock Soars on Growth Plans - 24 Apr, 2025
Morepen Laboratories announced ambitious growth plans, targeting ₹1,000 crore in its formulation business and launching four new products, leading to a stock surge of over 14%. The company aims to enhance market penetration and expand its product portfolio, reinforcing its commitment to innovation and quality in pharmaceuticals.
Insights on Morepen Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 442.71 Cr → 470.46 Cr (in ₹), with an average increase of 3.0% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 60.47% to 60.72% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, MOREPENLAB stock has moved up by 40.1%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 51.0% return, outperforming this stock by 2.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 35.65% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.4% return, outperforming this stock by 68.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 4 quarters, 36.17 Cr → 20.32 Cr (in ₹), with an average decrease of 17.0% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 2.22% to 1.94% in Mar 2025 quarter
About Morepen Laboratories
Revenue: ₹465.85Cr as on March 2025 (Q4 FY25)
Net Profit: ₹20.31Cr as on March 2025 (Q4 FY25)
Listing date: 15 May, 1995
Chairperson Name: Sushil Suri
| Organisation | Morepen Laboratories Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| CEO | Sushil Suri |
| E-voting on shares | Click here to vote |
Mutual Funds that own Morepen Laboratories
Check out the Mutual Funds with significant holdings in Morepen Laboratories.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Bandhan BSE Healthcare Index Fund Direct Growth | 0.17% |
FAQs
What is Morepen Laboratories share price today?
Morepen Laboratories share price today stands at ₹63.81, Open: ₹64.7, Previous Close: ₹64.58, High: ₹64.92, Low: ₹62.66, 52 Week High: ₹100.9, 52 Week Low: ₹42.
What is today's traded volume of Morepen Laboratories?
Today's traded volume of Morepen Laboratories is 34.57L. Which means that 34.57L shares of Morepen Laboratories were bought and sold on the stock market during today's trading session.
What is Morepen Laboratories's market cap today?
Today's market capitalisation of Morepen Laboratories is ₹3,538.68 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Morepen Laboratories?
Morepen Laboratories’s 52 week high is ₹100.9 and 52 week low is ₹42. The current share price of Morepen Laboratories is ₹63.81, which is -36.76% down from its 52 week high and 51.93% up from its 52 week low.